Plain-English translation of NCT06504511 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a three-year study that follows people with SCN1A-related epilepsy (including Dravet syndrome) to understand how the condition affects seizures, thinking, learning, behavior, and motor skills over time. Researchers will collect information from about 400 participants across the UK to build a clear picture of how this type of epilepsy progresses and what factors might affect that progression. This information will help doctors better understand whether new treatments are truly making a difference in people's lives.
While doctors know that SCN1A-related epilepsy can affect learning, development, and movement, there has never been a large, long-term study that carefully tracks how these changes happen over time. This study exists to fill that gap so that doctors can better measure whether new treatments are actually helping and understand which people may be at highest risk for complications.
You likely qualify if…
You likely don't qualify if…
Over three years, you would share information about your seizures, learning, behavior, and quality of life through regular visits (some can be done virtually). Researchers will use standardized tests and questionnaires to track how you're doing over time, but this is a natural history study—meaning they are observing and documenting your condition rather than testing a new medication or treatment. Your participation helps build a comprehensive picture of how SCN1A-related epilepsy affects people across their lifespan.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United Kingdom
Sponsor
NHS Greater Glasgow and Clyde
Enrollment target
~400 participants
Started
November 2023
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kirsty Hendry, PhD
NHS Greater Glasgow & Clyde
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.